Vacuum Blood Collection Device Market

Starting at US$ 5000

Buy Now
Companies
Market Size (2026)
USD 3.0 Bn
Forecast (2036)
USD 5.5 Bn
CAGR (2026 to 2036)
6.4%

Vacuum Blood Collection Device Market Size, Market Forecast and Outlook By FMI

The vacuum blood collection device market was valued at USD 2.8 billion in 2025. The market is set to reach USD 3.0 billion by 2026-end and grow at a CAGR of 6.4% between 2026-2036 to reach USD 5.5 billion by 2036. Serum Separation Tubes will dominate with a 23.5% share, while Diagnostic Centers will lead with a 45.0% share.

Vacuum Blood Collection Device Market Value Analysis
Vacuum Blood Collection Device Market Value Analysis

Key Takeaways, Market Size, and Forecast

MetricValue
Market Size (2026)USD 3.0 Billion
Market Size (2036)USD 5.5 Billion
Forecast CAGR6.4% from 2026 to 2036
Absolute $ OpportunityUSD 2.56 Billion between 2026 and 2036
Leading ProductSerum Separation Tubes
Serum Separation Tubes Share In 202623.5%
Fastest-Growing CountrySouth Korea
South Korea CAGR7.6% through 2036

Parameter Details
Market Size in 2026 (Value) USD 3.0 billion
Market Forecast in 2036 (Value) USD 5.5 billion
CAGR (2026 to 2036) 6.4%
Years Considered 2021 to 2036
Base Year 2026
Forecast Period 2026 to 2036
Units Considered Value (USD Bn)
Leading Sub-Region South Korea

Summary of the Vacuum Blood Collection Device Market

  • Demand and Growth Drivers
    • Rising diagnostic testing volumes driven by chronic disease prevalence and preventive health screening expansion are expected to sustain demand for vacuum blood collection devices through the forecast period.
    • Adoption of PET/plastic vacuum tubes is increasing due to safety advantages over glass including reduced breakage risk, lighter weight, and compatibility with automated pre-analytical systems.
    • Expansion of diagnostic laboratory infrastructure in South Asia and East Asia is broadening demand for vacuum blood collection systems beyond established markets in North America and Europe.
  • Product and Segment View
    • Serum separation tubes account for 23.5% of the product segment, reflecting high-volume procurement for routine clinical chemistry and immunoassay testing that requires serum specimen preparation.
    • Diagnostic centers hold 45.0% of the end-user segment, driven by outpatient blood collection volumes for routine and specialty diagnostic testing performed at reference and commercial laboratories.
    • PET/plastic tube materials are gaining share over glass, driven by safety compliance in clinical settings and compatibility with automated tube handling and centrifugation systems.
  • Geography and Competitive Outlook
    • South Korea is expected to lead growth at 7.6% CAGR through 2036, driven by advanced diagnostic infrastructure, health screening program expansion, and high per-capita laboratory testing rates.
    • North America accounts for the largest market share, sustained by high diagnostic testing volumes, established phlebotomy infrastructure, and comprehensive insurance coverage for laboratory diagnostics.
    • Becton, Dickinson and Company holds an estimated 23.0% market share, supported by the BD Vacutainer product platform and established hospital and laboratory distribution across global markets.
  • Analyst Opinion
    • Sabyasachi Ghosh, Principal Consultant at FMI says, 'Manufacturers that can deliver integrated pre-analytical systems combining vacuum collection, automated labeling, and specimen processing workflow are positioned to capture laboratory procurement share as diagnostic facilities invest in automation to manage increasing testing volumes with labor efficiency. The expansion of health screening in East and South Asia creates the primary volume growth channel.'
    • Growth reflects diagnostic testing volume expansion, pre-analytical automation investment, and health screening program proliferation across emerging markets.
    • Demand is supported by chronic disease monitoring requirements, preventive screening mandates, and increasing outpatient phlebotomy service volumes.
    • Adoption of safety-engineered needle devices is increasing as needlestick injury prevention regulations mandate protective features on blood collection systems.

Vacuum Blood Collection Device Market Definition

The vacuum blood collection device market includes evacuated blood collection tubes, needle holders, safety needles, butterfly collection sets, and tube accessories used for venipuncture and specimen collection in hospitals, diagnostic centers, blood banks, and clinical research settings.

Vacuum Blood Collection Device Market Inclusions

Market scope covers products segmented by product (serum separation tubes, EDTA tubes, heparin tubes, citrate tubes, glucose tubes, others), end user (diagnostic centers, hospitals, blood banks, clinical research), material (PET/plastic, glass), application (serology and immunology, hematology, coagulation, clinical chemistry), and technology (vacuum-based collection, safety-engineered). Revenue estimates span 2026 to 2036.

Vacuum Blood Collection Device Market Exclusions

The scope excludes capillary blood collection devices, arterial blood gas syringes, and urine specimen collection systems.

Vacuum Blood Collection Device Market Research Methodology

  • Primary Research: FMI analysts conducted interviews with laboratory directors, phlebotomy service managers, and blood collection device manufacturers across key markets.
  • Desk Research: Combined data from diagnostic laboratory testing volume databases, hospital procurement records, and medical device manufacturer disclosures.
  • Market Sizing and Forecasting: Bottom-up aggregation of diagnostic testing volumes, per-test tube consumption rates, and phlebotomy procedure data across clinical settings and regions.
  • Data Validation: Cross-checked quarterly against diagnostic testing statistics, medical supply trade data, and manufacturer revenue disclosures.

Why is the Vacuum Blood Collection Device Market Growing?

  • Diagnostic testing volume growth driven by chronic disease monitoring, preventive screening, and aging population healthcare utilization is generating sustained demand for vacuum blood collection devices across hospital and outpatient settings.
  • Pre-analytical automation in diagnostic laboratories is driving specification of standardized vacuum tube systems compatible with automated sorting, centrifugation, and analyzer loading equipment.
  • Safety-engineered blood collection devices with needlestick prevention features are gaining mandatory specification status as occupational safety regulations tighten across healthcare facilities globally.

The vacuum blood collection device market is expanding as diagnostic testing volumes grow and pre-analytical processes become increasingly automated. Vacuum tubes represent the standard specimen collection method in modern clinical laboratories, with each diagnostic test requiring one or more tube types depending on specimen requirements. Rising chronic disease prevalence creates recurring monitoring demand, while preventive screening programs create population-level testing volume that sustains high per-capita tube consumption.

Serum separation tubes dominate at 23.5%, serving the highest-volume testing applications including clinical chemistry panels, immunoassay testing, and serology. EDTA tubes for hematology, citrate tubes for coagulation testing, and heparin tubes for plasma chemistry represent complementary product categories that collectively address the full spectrum of laboratory testing requirements.

Geographic expansion reflects diagnostic infrastructure development. South Korea leads growth at 7.6% with advanced health screening programs that generate high per-capita testing volumes. India at 7.2% reflects expanding diagnostic chain networks serving growing outpatient testing demand. China at 6.5% benefits from hospital laboratory modernization and national health screening program expansion.

Market Segmentation Analysis

  • Serum separation tubes hold 23.5% of the product segment, sustained by high-volume clinical chemistry and immunoassay testing requiring serum specimens.
  • Diagnostic centers at 45.0% generate the largest end-user demand, with outpatient blood collection volumes for routine and specialty testing.
  • PET/plastic materials are gaining specification preference over glass for safety compliance and automated system compatibility.

The market is segmented by product, end user, material, application, and technology. Products include SST, EDTA, heparin, citrate, and glucose tubes. End users span diagnostic centers, hospitals, blood banks, and clinical research.

Insights into the Serum Separation Tube Segment

Vacuum Blood Collection Device Market Analysis By Product
Vacuum Blood Collection Device Market Analysis By Product

SSTs at 23.5% contain clot activator and gel separator that enables serum preparation through centrifugation. These tubes serve the broadest range of clinical chemistry and immunoassay tests, generating the highest per-tube consumption volume across diagnostic laboratories.

Procurement follows laboratory supply contracts with 1 to 3 year terms, with tube specification driven by analyzer compatibility, gel performance, and additive quality that affects test result accuracy.

Insights into the EDTA Tube Segment

EDTA tubes serve complete blood count and hematology testing, representing the second-largest product category by volume. K2-EDTA and K3-EDTA variants serve different analyzer and testing protocol requirements across clinical laboratories.

Vacuum Blood Collection Device Market Drivers, Restraints, and Opportunities

  • Diagnostic testing volume growth creates structural demand proportional to healthcare utilization and screening program expansion.
  • Safety-engineered device mandates add per-unit cost that increases procurement spending while reducing needlestick injury liability.
  • Pre-analytical automation drives standardization of tube specifications compatible with laboratory processing systems.

The market benefits from testing volume growth, safety regulation, and laboratory automation. Restraints include commodity pricing pressure and glass-to-plastic transition costs. Opportunities exist in emerging market diagnostic expansion, safety-engineered devices, and integrated pre-analytical systems.

Testing Volume Growth

Demand is shaped by increasing diagnostic testing utilization driven by chronic disease monitoring, preventive screening, and population health management programs that generate per-capita testing volume growth.

Safety Device Mandates

Growth reflects occupational safety regulations mandating needlestick prevention features on blood collection devices, with OSHA Bloodborne Pathogens Standard and EU Sharps Directive creating compliance-driven procurement.

Laboratory Automation

Adoption of automated pre-analytical systems drives tube specification standardization, with laboratories specifying vacuum tube brands compatible with their sorting, centrifugation, and loading equipment.

Analysis of Vacuum Blood Collection Device Market By Key Countries

Top Country Growth Comparison Vacuum Blood Collection Device Market Cagr (2026 2036)
Top Country Growth Comparison Vacuum Blood Collection Device Market Cagr (2026 2036)
Country CAGR
South Korea 7.6%
India 7.2%
China 6.5%
UK 3.6%
Germany 3.4%
USA 3.2%
Vacuum Blood Collection Device Market Cagr Analysis By Country
Vacuum Blood Collection Device Market Cagr Analysis By Country
  • South Korea leads growth at 7.6% CAGR, driven by national health screening programs generating high per-capita testing volumes and advanced diagnostic laboratory automation infrastructure.
  • India at 7.2% reflects expanding diagnostic chain networks, growing outpatient testing demand, and government health screening program implementation.
  • China (6.5%) and the UK (3.6%) sustain demand through hospital laboratory modernization, national screening programs, and pre-analytical automation investment.

The global vacuum blood collection device market is projected to grow at 6.4% CAGR from 2026 to 2036. The analysis covers more than 30 countries, with key markets discussed below.

Demand Outlook for Vacuum Blood Collection Device Market in South Korea

National health screening programs and advanced diagnostic infrastructure generate high per-capita testing volumes. Growth at 7.6% through 2036 reflects NHIS health check-up program expansion, laboratory automation, and diagnostic precision requirements.

  • NHIS national health screening program mandates regular health check-ups that generate population-level blood collection volumes sustaining tube procurement demand.
  • Korean diagnostic laboratories invest in automated pre-analytical systems that specify BD Vacutainer and Greiner Vacuette tube compatibility for workflow integration.
  • High diagnostic technology adoption enables rapid specification of advanced tube products including barcode-labeled and RFID-tagged specimens for traceability.

Sales Analysis of Vacuum Blood Collection Device Market in India

Diagnostic chain expansion and government screening programs are driving blood collection device procurement. Growth at 7.2% through 2036 reflects Ayushman Bharat health screening, private lab network growth, and organized phlebotomy service development.

  • Diagnostic chains including Thyrocare, SRL, and Dr. Lal PathLabs are expanding specimen collection networks across tier-2 and tier-3 cities, creating distributed blood collection device procurement.
  • Ayushman Bharat health screening components generate institutional blood collection volume through government hospital and primary health center diagnostic programs.
  • Domestic manufacturers including Poly Medicure and HMD are scaling vacuum tube production capacity to serve growing Indian diagnostic market demand at competitive pricing.

In-depth Analysis of Vacuum Blood Collection Device Market in China

Hospital laboratory modernization and national health screening investment define the Chinese market. Growth at 6.5% through 2036 reflects diagnostic capacity expansion, domestic manufacturer advancement, and automation adoption.

  • Government hospital equipment modernization programs include diagnostic laboratory upgrades that generate procurement demand for standardized vacuum blood collection systems.
  • Domestic manufacturers including Guangzhou Improve Medical and Shandong Weigao supply vacuum tubes at competitive pricing for Chinese hospital procurement channels.
  • National health screening programs for chronic disease prevention create population-level testing volumes that sustain blood collection device demand across provincial healthcare networks.

Opportunity Analysis of Vacuum Blood Collection Device Market in the United Kingdom

NHS diagnostic modernization and phlebotomy service reorganization shape the UK market. Growth at 3.6% through 2036 reflects Community Diagnostic Centre expansion, safety device compliance, and pre-analytical standardization.

  • NHS Community Diagnostic Centre program creates new outpatient blood collection facilities that require vacuum tube and safety device procurement for diagnostic testing services.
  • EU Sharps Directive-equivalent UK regulations mandate safety-engineered blood collection devices in NHS and private healthcare settings, driving specification of protected needle systems.
  • NHS Supply Chain framework agreements standardize vacuum tube procurement specifications across trust facilities, creating volume purchasing that favors established manufacturers.

Future Outlook for Vacuum Blood Collection Device Market in the United States

Established diagnostic infrastructure and high per-capita testing rates define the US market. Growth at 3.2% through 2036 reflects outpatient testing expansion, safety device mandates, and laboratory automation upgrades.

  • OSHA Bloodborne Pathogens Standard mandates safety-engineered blood collection devices, sustaining procurement of protected needle systems across US healthcare facilities.
  • Reference laboratory consolidation by Quest Diagnostics and Labcorp generates centralized vacuum tube procurement through national supply contracts.
  • Patient service center expansion for outpatient blood collection creates distributed phlebotomy infrastructure that generates incremental vacuum tube consumption.

Competitive Landscape and Strategic Positioning

Vacuum Blood Collection Device Market Analysis By Company
Vacuum Blood Collection Device Market Analysis By Company
  • Becton, Dickinson and Company holds an estimated 23.0% market share, supported by the BD Vacutainer platform, global hospital and laboratory distribution, and integrated pre-analytical system solutions.
  • Greiner Bio-One International GmbH maintains a strong position through the Vacuette vacuum tube platform, established European distribution, and growing global market presence.
  • SARSTEDT AG serves the diagnostic laboratory market with the S-Monovette collection system and Monovette tube portfolio, particularly strong in European markets.

BD leads with an estimated 23.0% share through the Vacutainer platform, the most recognized vacuum blood collection brand globally. The company benefits from integrated pre-analytical solutions spanning collection, processing, and specimen management.

Greiner Bio-One competes with the Vacuette platform, offering a comprehensive tube portfolio with competitive pricing and established European distribution. SARSTEDT provides the S-Monovette aspiration-based collection system that offers an alternative to pure vacuum collection.

Guangzhou Improve Medical and AB Medical serve Asian markets with cost-competitive vacuum tube products. Cardinal Health distributes blood collection products through its medical supply channels.

Barriers include clinical validation requirements for tube additive performance, laboratory analyzer compatibility testing, safety-engineered device regulatory clearance, and the distribution infrastructure needed to serve hospitals, diagnostic centers, and phlebotomy services.

Key Companies in the Vacuum Blood Collection Device Market

Key global companies leading the vacuum blood collection device market include:

  • Becton, Dickinson and Company (USA), Greiner Bio-One (Austria), and SARSTEDT AG (Germany) lead with established vacuum collection platforms, global laboratory distribution, and pre-analytical system integration.
  • Guangzhou Improve Medical (China), AB Medical (Japan), and Cardinal Health (USA) maintain positions through regional manufacturing, cost-competitive pricing, and medical supply distribution channels.
  • Poly Medicure Ltd. (India), InterVac Technology (China), and Nipro Corporation (Japan) serve emerging market and specialized segments with cost-effective vacuum collection products and regional distribution.

Competitive Benchmarking: Vacuum Blood Collection Device Market

Company Product Range Pre-analytical Integration Lab Distribution Geographic Footprint
Becton Dickinson High High Strong Global
Greiner Bio-One High Medium Strong Europe, Global
SARSTEDT AG High Medium Strong Europe, Global
Guangzhou Improve Medium Low Moderate China, Asia
AB Medical Medium Low Moderate Japan, Asia
Cardinal Health Medium Low Strong N. America
Poly Medicure Medium Low Moderate India
InterVac Technology Low Low Moderate China
Nipro Corporation Medium Low Moderate Japan, Global

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Vacuum Blood Collection Device Market

  • In 2025, Becton Dickinson introduced an updated BD Vacutainer tube series with enhanced gel separator performance and barcode labeling for automated pre-analytical laboratory workflow integration.
  • In 2025, Greiner Bio-One launched a safety-engineered blood collection needle platform with integrated needlestick prevention compliant with EU Sharps Directive requirements for European healthcare facilities.

Key Players in the Vacuum Blood Collection Device Market

Major Global Players

  • Becton, Dickinson and Company
  • Greiner Bio-One International GmbH
  • SARSTEDT AG and Co. KG
  • Cardinal Health, Inc.
  • AB Medical Inc.

Emerging Players/Startups

  • Guangzhou Improve Medical Instruments Co., Ltd.
  • Poly Medicure Ltd.
  • InterVac Technology
  • Nipro Corporation
  • HMD Healthcare Ltd.

Report Scope and Coverage

Vacuum Blood Collection Device Market Breakdown By Product, End User, And Region
Vacuum Blood Collection Device Market Breakdown By Product, End User, And Region
Parameter Details
Market size by 2036 USD 5.5 billion
Growth rate 6.4% CAGR (2026 to 2036)
Forecast period 2026 to 2036
Base year value (2026) USD 3.0 billion
By Product Serum Separation Tubes, Serum Clot Activators/Serum Gel + Clot Activator, Plasma Analysis/Anti-coagulant, Coagulation Analysis Tubes, Glucose Analysis Tubes, Others
By End User Diagnostic Centers, Hospitals and Clinics, Research and Academic Institutes, Veterinary Hospitals and Clinics, Others
By Material PET/Plastic, Glass
By Application Serology and Immunology, Routine Chemistry, Blood Typing, Molecular Genetics, Blood Sugar Assay, Others
By Technology Vacuum Based Collection, Capillary Blood Collection, Safety Engineered Devices
Regions covered North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered USA, UK, Germany, France, South Korea, Japan, China, India, 30 plus countries
Key companies profiled BD, Greiner Bio-One, SARSTEDT, Cardinal Health, AB Medical, Guangzhou Improve, Poly Medicure, InterVac, Nipro
Approach Hybrid bottom-up and top-down methodology starting with diagnostic testing volumes and per-test tube consumption, projecting demand across products and regions.

Segmentation

Vacuum Blood Collection Device Market Segmented by Product:

  • Serum Separation Tubes
    • Gel Based Separation Tubes
      • Clot Activator Gel Tubes
      • Polymer Gel Tubes
    • Plain Serum Tubes
      • Without Additive Tubes
      • Silicone Coated Tubes
  • Serum Clot Activators/Serum Gel + Clot Activator
    • Dual Additive Tubes
      • Gel With Clot Activator Tubes
      • Rapid Clot Activator Tubes
    • High Efficiency Separation Tubes
      • Enhanced Barrier Tubes
      • Fast Centrifugation Tubes
  • Plasma Analysis/Anti-coagulant
    • EDTA Tubes
      • K2 EDTA Tubes
      • K3 EDTA Tubes
    • Heparin Tubes
      • Lithium Heparin Tubes
      • Sodium Heparin Tubes
  • Coagulation Analysis Tubes
    • Sodium Citrate Tubes
      • Buffered Citrate Tubes
      • Non Buffered Citrate Tubes
    • Specialty Coagulation Tubes
      • Low Volume Tubes
      • High Sensitivity Tubes
  • Glucose Analysis Tubes
    • Fluoride Oxalate Tubes
      • Sodium Fluoride Tubes
      • Potassium Oxalate Tubes
    • Glucose Stabilization Tubes
      • Citrate Fluoride Tubes
      • Inhibitor Based Tubes
  • Others
    • Specialty Collection Tubes
      • Trace Element Tubes
      • Heavy Metal Free Tubes

Vacuum Blood Collection Device Market Segmented by End User:

  • Diagnostic Centers
    • Standalone Diagnostic Laboratories
      • High Volume Laboratories
      • Specialty Diagnostic Laboratories
    • Chain Diagnostic Centers
      • Urban Diagnostic Chains
      • Rural Diagnostic Chains
  • Hospitals and Clinics
    • Public Hospitals
      • Government Hospitals
      • Municipal Hospitals
    • Private Hospitals
      • Multi Specialty Hospitals
      • Single Specialty Clinics
  • Research and Academic Institutes
    • University Laboratories
      • Clinical Research Laboratories
      • Academic Research Centers
    • Independent Research Organizations
      • Contract Research Organizations
      • Non Profit Research Institutes
  • Veterinary Hospitals and Clinics
    • Small Animal Clinics
      • Companion Animal Clinics
      • Pet Care Clinics
    • Large Animal Facilities
      • Livestock Clinics
      • Equine Clinics
  • Others
    • Home Healthcare Settings
      • Home Collection Services
      • Mobile Phlebotomy Units

Vacuum Blood Collection Device Market Segmented by Material:

  • PET/Plastic
    • Polyethylene Terephthalate Tubes
      • Clear Plastic Tubes
      • Amber Plastic Tubes
    • Multi Layer Plastic Tubes
      • Barrier Coated Tubes
      • Vacuum Stable Tubes
  • Glass
    • Borosilicate Glass Tubes
      • Standard Glass Tubes
      • High Clarity Glass Tubes
    • Siliconized Glass Tubes
      • Coated Interior Tubes
      • Non Reactive Surface Tubes

Vacuum Blood Collection Device Market Segmented by Application:

  • Serology and Immunology
    • Infectious Disease Testing
      • Antibody Detection Tests
      • Antigen Detection Tests
    • Autoimmune Testing
      • Rheumatoid Testing
      • Allergy Testing
  • Routine Chemistry
    • Metabolic Panel Testing
      • Liver Function Tests
      • Kidney Function Tests
    • Electrolyte Testing
      • Sodium Potassium Tests
      • Calcium Magnesium Tests
  • Blood Typing
    • ABO Grouping
      • Forward Grouping Tests
      • Reverse Grouping Tests
    • Rh Typing
      • Positive Negative Typing
      • Weak D Testing
  • Molecular Genetics
    • DNA Analysis
      • Genotyping Tests
      • Sequencing Preparation
    • RNA Analysis
      • Gene Expression Studies
      • Transcript Analysis
  • Blood Sugar Assay
    • Fasting Glucose Testing
      • Baseline Glucose Tests
      • Pre Meal Tests
    • Postprandial Testing
      • After Meal Tests
      • Glucose Tolerance Tests
  • Others
    • Specialized Diagnostic Testing
      • Hormone Testing
      • Tumor Marker Testing

Vacuum Blood Collection Device Market Segmented by Technology:

  • Vacuum Based Collection
    • Pressure Controlled Systems
      • Pre Evacuated Tubes
      • Calibrated Vacuum Tubes
    • Closed System Collection
      • Sterile Closed Tubes
      • Contamination Free Systems
  • Capillary Blood Collection
    • Micro Collection Systems
      • Fingerstick Collection Tubes
      • Heel Stick Collection Tubes
    • Low Volume Collection Systems
      • Pediatric Micro Tubes
      • Geriatric Micro Tubes
  • Safety Engineered Devices
    • Needle Safety Mechanisms
      • Retractable Needles
      • Shielded Needles
    • Contamination Prevention Systems
      • Leak Proof Tubes
      • Tamper Resistant Tubes

Vacuum Blood Collection Device Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • 1. World Health Organization. (2025). WHO Guidelines on Blood Collection Practices. WHO.
  • 2. Clinical and Laboratory Standards Institute. (2024). CLSI GP41 Collection of Blood Specimens by Venipuncture. CLSI.
  • 3. USA Occupational Safety and Health Administration. (2025). OSHA Bloodborne Pathogens Standard. OSHA.
  • 4. European Committee for Standardization. (2024). EN ISO 6710 Single-Use Containers for Venous Blood Specimen Collection. CEN.
  • 5. International Organization for Standardization. (2025). ISO 6710 Vacuum Blood Collection Tube Standards. ISO.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

  • Estimating market size and revenue from 2026 to 2036.
  • Segmentation by product, end user, material, application, and technology.
  • Regional insights across more than 30 markets.
  • Technology analysis covering vacuum collection, safety devices, and pre-analytical automation.
  • Competitive landscape assessment.
  • Investment opportunities in emerging market diagnostics and safety-engineered devices.
  • Supply chain and laboratory distribution analysis.
  • Data delivery in PDF and Excel formats.

Frequently Asked Questions

How big is the vacuum blood collection device market in 2026?

The global vacuum blood collection device market is estimated to be valued at USD 3.0 billion in 2026.

What will be the size of vacuum blood collection device market in 2036?

The market size for the vacuum blood collection device market is projected to reach USD 5.5 billion by 2036.

How much will be the vacuum blood collection device market growth between 2026 and 2036?

The vacuum blood collection device market is expected to grow at a 6.4% CAGR between 2026 and 2036.

What are the key products in the vacuum blood collection device market?

The key products in vacuum blood collection device market are Serum Separation Tubes, Serum Clot Activators/Serum Gel + Clot Activator, Plasma Analysis/Anti-coagulant, Coagulation Analysis Tubes, Glucose Analysis Tubes and Others.

Which end user segment is expected to contribute significant share in the vacuum blood collection device market in 2026?

In terms of end user, diagnostic centers segment is expected to command 45.0% share in the vacuum blood collection device market in 2026.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Vacuum Blood Collection Device Market